Company intelligence / Profile preview

Schaper & Brümmer GmbH & Co. KG

Salzgitter-Ringelheim, Lower Saxony, Germanyplay.google.com ↗

Ownership: Private
Employees: ~140
Development stage: Commercial

Overview

The company has conducted several clinical trials including a pharmacy-based non-interventional study assessing Esberitox® COMPACT for colds, a post-market clinical follow-up study of Remifemin® FeuchtCreme vaginal cream, and a study on the effect of a plant extract dietary supplement on psychopathologic stress reactions[5].

Therapeutic areas: Men's HealthPsychiatryInfectious DiseasesWomen's Health
Modalities: Herbal medicine
Industry: Biotech

Drug pipeline

8 assets

feverfew CO2-extract

Unknown

7 more assets in the full pipeline.

Request access →

Partnerships

Business partners worldwide in over 40 countries[1]

Beyond the preview

Go deeper on Schaper & Brümmer GmbH & Co. KG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schaper & Brümmer GmbH & Co. KG.

Explore the full profile